Abstract. Toll-like receptor (TLR) family members are pattern recognition receptors that are essential in the activation of innate and adaptive immune responses. Submandibular gland epithelial cells (SMGCs) may recognize microbial components through TLRs and be involved in the development of inflammatory reactions in the submandibular glands.
Introduction
Host recognition of microbes is primarily mediated by Toll-like receptors (TLRs), which bind highly conserved pathogen-associated molecular patterns (PAMPs) typically shared by groups of microorganisms (1) . Each member of the TLR family has been shown to recognize the PAMPs of bacteria, fungi and/or viruses (2, 3) . TLR2 forms a heterodimer with either TLR1 or TLR6 to recognize bacterial tri-or diacyl-lipopeptides, while TLR3, 4 and 5 recognize double-stranded RNA, Gram-negative bacterial lipopolysaccharide (LPS) and bacterial flagellin, respectively. TLR7 and 8 recognize single-stranded RNA found in certain viruses, and TLR9 recognizes the hypomethylated CpG motifs of bacterial DNA. However, the PAMP recognized by TLR10 is unknown. Following ligation, TLR signaling results in priming of the adaptive immune system and initiation of inflammatory responses via the induction of pro-inflammatory cytokines and chemokines (4, 5) . In addition, activation of TLRs appears to be involved in the pathogenesis of autoimmune disorders, as suggested by the induction or promotion of organ-specific autoimmune lesions observed in various experimental animal models (6) (7) (8) .
The expression of various types of TLR molecules in several types of epithelial tissue, including oral, gastrointestinal, bronchial and urinary epithelia, supports the hypothesis that the epithelium serves a critical function as the defensive front line of the innate immune system (9-11). TLRs in salivary glands have also been shown to be associated with the promotion of inflammatory reactions in autoimmune diseases, such as Sjögren's syndrome (SS) and autoimmune sialoadinitis (12, 13) . Therefore, submandibular gland epithelial cells (SMGCs) appear to be actively involved in the induction of tissue reactions against pathogens in inflammatory autoimmune diseases via TLRs in the salivary glands.
Cytokines have a central role in the regulation of immunity, but dysregulation of the cytokine network can contribute to autoimmune disorders in salivary glands (14) . Tumor necrosis factor (TNF)-α and interleukin (IL)-8 have been identified in functionally and structurally damaged areas of salivary glands, and have also been implicated in disease pathogenesis (15) (16) (17) .
Previously, various TLR agonists were shown to cause secretion of pro-inflammatory cytokines, such as IL-8, and augment TNF-α-mediated inflammatory responses in oral keratinocytes and fibroblasts (18) . These findings may suggest that inflammatory cytokines in SMGCs are induced by PAMPs and implicated in the development of TNF-α-mediated inflammatory diseases of the salivary glands. In the present study, IL-8 production from SMGCs in response to various TLR agonists was examined. The combined effect of TLR agonists and TNF-α on the production of IL-8 was also investigated.
Materials and methods
Cell lines. Primary cultures of human SMGCs obtained from patient specimens extracted during submandibular gland extraction surgery for sialolithiasis (Hiroshima University Hospital, Hiroshima, Japan) were prepared. Informed consent from all participants was obtained according to a protocol approved by the Ethics Committee of Hiroshima University, Japan. SMGCs were established using an explant outgrowth technique, as previously described (19) . At 70-80% confluence, each primary culture was trypsinized, then serially transferred to culture vessels in serum-free keratinocyte basal medium (KBM; Lonza, Walkersville, MD, USA) as described previously (19) . For molecular analyses, normal submandibular gland tissues at the time of submandibular gland extraction surgery, subsequent to obtaining informed consent and approval from the Institutional Review Board at Hiroshima University Hospital, were collected and frozen immediately in liquid nitrogen, and stored at -80˚C.
RNA extraction and reverse transcription-polymerase chain reaction (RT-PCR).
Total RNA was prepared from SMGCs and whole submandibular gland tissues using an RNeasy total RNA isolation kit (Qiagen, Hilden, Germany). Single-stranded cDNA for a PCR template was synthesized from a First Strand cDNA Synthesis kit (Amersham Biosciences, Uppsala, Sweden). Target cDNA was amplified by PCR with an RT-PCR High Plus system (Toyobo, Osaka, Japan), using the following specific primers: Sense: 5'-AATTGATCTGGGTGGTGAGC-3' and antisense: 5'-GCCAACGGTAGCTTGACATT-3' for amylase; sense: 5'-CCGTGTCCAAGAAAACCAGA-3' and antisense: 5'-CAGCTGTGTGATGGGAGCTA-3' for chromogranin B; sense: 5'-GCCAAGCAGACGAGGACTAC-3' and antisense: 5'-GGAGCACACCATCACACATC-3' for kallikrein I; and sense: 5'-GGTCAGGCTCTCTTCACTGG-3' and antisense: 5'-CCCTTCCCCCAGTTGAGTAT-3' for claudin I. The PCR conditions were as follows: One cycle at 95˚C for 15 min, four cycles of 95˚C for 2 min, 59˚C for 30 sec and 72˚C for 1 min and one cycle at 72˚C for 7 min. The products were analyzed on 2% agarose gels. β-actin was included as an internal control.
TLR agonists. The TLR agonists used in this study were purchased from Imgenex Corporation (San Diego, CA, USA) and included Pam3CSK4, a synthetic bacterial lipopeptide (TLR1/2 agonist); poly I:C, a synthetic virus double-stranded RNA (TLR3 agonist); E. coli LPS, a synthetic cell wall component of gram-negative bacteria (TLR4 agonist); flagellin from Salmonella Typhimurium, a synthetic bacterial flagellin (TLR5 agonist); macrophage-activating lipopeptide (MALP-2), a synthetic Mycoplasma lipopeptide (TLR2/6 agonist); imiquimod (R-837), a synthetic molecule of the Imidazoquinoline family (TLR7 agonist); synthetic oligodeoxynucleotide (ODN) containing CpG motifs; and a synthetic bacterial DNA (TLR9 agonist).
Quantification of IL-8 protein.
SMGCs were seeded into 96-well cell culture plates in KBM. To determine the maximal effective TLR agonist concentration with regard to activating capacity, IL-8 production was assessed following stimulation with the following agonists at various doses: 100 ng/ml-5 µg/ml Pam3CSK4, 100 ng/ml-5 µg/ml poly I:C, 1-20 µg/ml LPS, 10-500 ng/ml flagellin, 10-500 ng/ml MALP-2 and 0.1-10 µg/ml imiquimod. As determined by these results, in subsequent experiments, cells were exposed to 1 µg/ml Pam3CSK4, 1 µg/ml poly I:C, 10 µg/ml E. coli LPS, 100 ng/ml flagellin, 500 ng/ml MALP-2, 10 µg/ml imiquimod, 10 µg/ml CpG-ODN or GpC (negative ODN) as a negative control to CpG-ODN. To half these cells, 10 ng/ml TNF-α was added, and the cells were incubated for 48 h.
The collected medium samples were centrifuged and the supernatant fluids stored at -80˚C prior to performing assays. The IL-8 protein level in the medium was determined using an ELISA kit (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions.
Statistical analysis. Data were analyzed using Student's t-test or one-way analysis of variance using the Bonferroni or Dunn method and the results are presented as the mean ± standard deviation. 
A B Results
Establishment of SMGCs. SMGCs were established using an explant outgrowth method (19) . The epithelial origin of cultured SMGCs was verified by morphology and uniformity (Fig. 1A) , and SMGCs were also shown to constitutively express salivary gland-associated genes, such as amylase, chromogranin B, kallikrein 1 and claudin 1 (Fig. 1B) (19, 20) . 
Effects of TLR agonists on IL-8 expression levels in SMGCs.
Since functional TLRs induce biological responses, the effects of various TLR agonists on IL-8 expression levels in SMGCs were examined. Pam3CSK4 (TLR1/2), poly I:C (TLR3), E. coli LPS (TLR4), flagellin (TLR5) and MALP-2 (TLR2/6) each significantly increased IL-8 production in a dose-dependent manner (P<0.05), whereas no statistically significant effect was exerted by imiquimod (TLR7) or CpG-ODN (TLR9) (Fig. 3) .
Effects of PAMPs on TNF-α-induced IL-8 production in
SMGCs. The effects of combinations of TLR agonists and TNF-α on IL-8 expression levels were also examined. TNF-α significantly increased IL-8 production in SMGCs in a dose-dependent manner (P<0.05; Fig. 4A ), while Pam3CSK4, poly I:C, LPS, flagellin and MALP-2 significantly enhanced TNF-α-induced IL-8 production in SMGCs, when compared with either the respective TLR agonist or TNF-α administered alone (P<0.05; Fig. 4B ).
Discussion
TLRs are essential in the activation of innate and adaptive immune responses in salivary gland inflammation (12) . mRNA expression of various TLR family members has been reported in whole human salivary gland tissues containing heterogeneous cell populations (21, 22) . In addition, certain studies have shown that salivary gland epithelial cells (SGECs) constitutively express particular TLRs. SGECs derived from SS patients and non-neoplastic SGECs in labial minor salivary glands were observed to exhibit marked constitutive expression of TLR1, 2, 3 and 4 mRNA (12). Furthermore, TLR1-5 were found to be expressed in salivary gland adenocarcinoma cells (23) . SMGCs derived from minor salivary glands were determined to express TLR2, 3 and 7, but not TLR9 (24) . In another study, TLR7 and TLR9 were detected in ductal epithelial cells in parotid gland biopsy specimens obtained from SS patients and control subjects (25) . In the present study, SMGCs and whole submandibular gland tissue specimens were shown to constitutively express TLR1-10 mRNA. Furthermore, imiquimod (TLR7 agonist) and CPG-ODN (TLR9 agonist) were found to exert no effect on IL-8 induction in SMGCs. It is unknown whether TLR7 and TLR9 in SMGCs function to recognise PAMPs. Therefore, the roles of TLR7 and TLR9 in SGECs may remain controversial. Stimulation of TLR signaling results in the production and expression of inflammatory mediators, including IL-6, IL-8 and TNF-α (1-3), which are critically involved in the disease processes of human inflammatory disorders. Local TLR expression has been reported in SS and autoimmune sialadenitis (12, 13) . Peptidoglycan (PGN; TLR2 agonist), poly I:C (TLR3 agonist) and LPS (TLR4 agonist) were found to increase CD54 and IL-6 expression levels in labial salivary gland cells (26) . Furthermore, flagellin (TLR5 agonist) led to production of IL-6 and IL-8 in salivary gland adenocarcinoma samples, although Pam3 (TLR1/2 agonist) and LPS (TLR4 agonist) did not exert an effect on cytokine production (23). Poly I:C (TLR3 agonist) treatment was shown to increase interferon and inflammatory cytokine expression levels in mice salivary gland cells (27) . In the present study, IL-8 production from SMGCs was found to be induced by TLR1/2, 3, 4, 5 and 2/6 agonists, of which poly I:C, a TLR3 agonist, markedly induced the production of IL-8. Thus, the presence of TLR3 suggests a role of the submandibular gland cells in the antiviral response.
Pro-inflammatory cytokines, such as TNF-α, have been reported to be associated with salivary gland loss of function and destruction. SGECs in SS biopsy samples were observed to produce TNF-α mRNA in greater quantities than SGECs from individuals with histologically normal minor salivary and TNF-α, administered alone or in combination. Cells were cultured, then exposed to 1 µg/ml Pam3CSK4, 1 µg/ml poly I:C, 10 µg/ml E. coli LPS, 100 ng/ml flagellin, 500 ng/ml MALP-2, 10 µg/ml imiquimod, 10 µg/ml CpG-ODN or GpC (negative ODN) as a negative control to CpG-ODN. An additional 10 ng/ml TNF-α was added to half the cells in each treatment group, and the cells were incubated for 48 h, subsequent to which the levels of IL-8 in the culture supernatants were measured by ELISA. Data are shown as the mean ± standard deviation of three independent experiments. (15) . Also, TNF-α secreted by infiltrating lymphocytes induced ductal Fas expression and ductal apoptosis in sialoadenitis associated with SS (28) . The present study demonstrated that the addition of TLR1/2, 3, 4, 5 and 2/6 agonists resulted in an increase in TNF-α-induced IL-8 production in SMGCs. IL-8 is important for neutrophil activation and recruitment, and undue downregulation of this function may compromise the antimicrobial defense. However, an unduly vigorous or sustained IL-8 response may result in chronic inflammatory tissue destruction (29) . Certain investigators have reported that increases in various TLR expression levels were identified in SGECs in the minor salivary gland of patients with SS, as compared with control subjects (12, 26) . Therefore, pro-inflammatory cytokines, including IL-8, induced by various PAMPs via TLRs may be implicated in the development of TNF-α-mediated autoimmune inflammatory disease of the submandibular glands.
With the majority of TLR agonists, the signaling pathways are mainly mediated by the activation of NF-κB and mitogen-activated protein kinase (MAPK), although cell-surface TLR4 and intracellular TLRs (TLR3, 7, 8 and 9) also activate cells via interferon regulatory factor (IRF)-3 and/or IRF-7 (30) . It has been reported that PGN, poly (I:C) and LPS also induced activation of the NF-κB and p38 MAPK pathways in SGECs in the minor salivary gland (26, 31) , while TNF-α activates nuclear factor-κB, which is involved in inflammatory cytokine signaling pathways, such as IL-8 and IL-6 via MAPK (32, 33) . In the present study, TNF-α-induced IL-8 production was enhanced by almost all TLR ligands, which may be explained by cooperative signaling among TNF-α and TLR agonists to induce IL-8 in SMGCs.
In conclusion, the results of the present study demonstrated that SMGCs expressed TLR1-10 mRNA, that IL-8 production from SMGCs was induced by treatment with various TLR agonists and that the TLR agonists regulated TNF-α-induced IL-8 production. This suggests that innate immune responses against microbial components result in the development of TNF-α-mediated autoimmune inflammatory disease in the submandibular glands.
